| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 3801212 | Medicina Clínica | 2010 | 4 Pages |
Abstract
In this cohort of patients, most of them old and with cardiovascular risk factors, the administration of non-pegylated liposomal doxorubicin as part of R-COMP regimen was effective and safe.
Related Topics
Health Sciences
Medicine and Dentistry
Medicine and Dentistry (General)
Authors
Miriam Moreno, Juan-Manuel Sancho, Santiago Gardella, Rosa Coll, Olga GarcÃa, David Gallardo, Josep-MarÃa Ribera,